強力な治療用タンパク質として機能する生体工学的に作られたタンパク質は、すべての生物学的プロセスに不可欠な役割を果たすように作られています。これらのユニークな医薬品は、その特異性、安全性、生物学的反応性、深刻な病気や怪我の治療における成功率から、製薬業界の関心を集めています。バイオエンジニアリングされたタンパク質から作られた薬は、生物学的プロセスや効果的な治療薬の開発において重要な役割を担っています。バイオエンジニアリングタンパク質医薬品には、ホルモン、ワクチン、サイトカイン、モノクローナル抗体など、さまざまな項目が含まれています。バイオエンジニアリングタンパク質医薬品市場は、がんや糖尿病など様々な疾病の増加や個別化医療の進展などの要因によって拡大しています。
国際がん研究機関（IARC）の推計によると、2018年のがんの新規発生件数は1,700万件、がん関連死亡件数は950万件で、2040年には2,750万件に増加すると推定されています。慢性疾患の中で最も成長速度が速いものひとつに糖尿病があります。ここ数十年で、その有病率は着実に増加しています。世界保健機関は、2021年までに糖尿病が全世界で5億3,700万人に達し、10人に1人が他の疾患を発症すると予測しています。さらに、高齢で太っている集団は、慢性疾患を発症する可能性が高くなります。世界銀行グループ（World Bank Group）の推計によると、2020年の世界の高齢者数は7億2,700万人で、今後30年間で3倍に増え、2050年には15億人に達すると言われています。また、この地域における創薬活動の活発化、ヘルスケア研究開発活動の活発化が、市場の成長を促しています。しかし、バイオエンジニアリングタンパク質医薬品のコストが高いため、2022年から2029年の予測期間を通じて市場成長を阻害しています。
世界のバイオエンジニアリングタンパク質医薬品市場調査の対象となる主要地域には、アジア太平洋、北アメリカ、ヨーロッパ、ラテンアメリカ、および世界のその他の地域含まれます。北アメリカは、ブランド製品の優位性とこの地域の疾患有病率の増加により、売上高で市場を独占しています。一方、アジア太平洋地域は、老年人口や対象人口の増加、製品開拓のための共同研究の増加、主要企業の地域的拡大、政府機関や非営利団体の市場参入などの要因から、予測期間中に最高のCAGRで成長すると予想されます。
この調査の目的は、近年のさまざまなセグメントおよび国の市場規模を定義し、今後数年間の市場規模を予測することです。この報告書は、調査に参加している国の業界の定性的および定量的側面の両方を組み込むように設計されています。
このレポートは、市場の将来の成長を定義する推進要因や課題などの重要な側面に関する詳細情報も提供します。さらに、競争環境と主要企業の製品提供の詳細な分析とともに、利害関係者が投資できるミクロ市場における潜在的な機会も組み込まれています。
目次
Table of Contents
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Bioengineered protein drugs Market, by Region, 2019-2029 (USD Billion)
1.2.2. Bioengineered protein drugs Market, by Drug Type, 2019-2029 (USD Billion)
1.2.3. Bioengineered protein drugs Market, by Diseases, 2019-2029 (USD Billion)
1.2.4. Bioengineered protein drugs Market, by Technology, 2019-2029 (USD Billion)
1.2.5. Bioengineered protein drugs Market, by Drug Delivery Method, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Bioengineered protein drugs Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Bioengineered protein drugs Market Dynamics
3.1. Bioengineered protein drugs Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Increasing prevelance of various diseases such as cancer and diabetes
3.1.1.2. Growing development of personalised medicine
3.1.2. Market Challenges
3.1.2.1. High Cost of Bioengineered protein drugs
3.1.3. Market Opportunities
3.1.3.1. Advancements in Formulation
Chapter 4. Global Bioengineered protein drugs Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Bioengineered protein drugs Market, by Drug Type
6.1. Market Snapshot
6.2. Global Bioengineered protein drugs Market by Drug Type, Performance - Potential Analysis
6.3. Global Bioengineered protein drugs Market Estimates & Forecasts by Drug Type 2019-2029 (USD Billion)
6.4. Bioengineered protein drugs Market, Sub Segment Analysis
6.4.1. Recombinant Protein Drugs
6.4.2. Peptide Hormones
6.4.3. Vaccines
6.4.4. Therapeutic Enzymes
6.4.5. Monoclonal Antibodies
6.4.6. Cytokines
6.4.7. Others
Chapter 7. Global Bioengineered protein drugs Market, by Diseases
7.1. Market Snapshot
7.2. Global Bioengineered protein drugs Market by Diseases, Performance - Potential Analysis
7.3. Global Bioengineered protein drugs Market Estimates & Forecasts by Diseases 2019-2029 (USD Billion)
7.4. Bioengineered protein drugs Market, Sub Segment Analysis
7.4.1. Diabetes
7.4.2. Cancer
7.4.3. Skin Diseases
7.4.4. Blood disorders
7.4.5. Heart Diseases
7.4.6. Neurodegenerative Diseases
7.4.7. Others
Chapter 8. Global Bioengineered protein drugs Market, by Technology
8.1. Market Snapshot
8.2. Global Bioengineered protein drugs Market by Technology, Performance - Potential Analysis
8.3. Global Bioengineered protein drugs Market Estimates & Forecasts by Technology 2019-2029 (USD Billion)
8.4. Bioengineered protein drugs Market, Sub Segment Analysis
8.4.1. Fractionation
8.4.2. Bioreactors And Microbial Cell Fermentation
8.4.3. Genetic Engineering
8.4.4. Genetically Modified Organisms
8.4.5. Pharming
8.4.6. Others
Chapter 9. Global Bioengineered protein drugs Market, by Drug Delivery Method
9.1. Market Snapshot
9.2. Global Bioengineered protein drugs Market by Drug Delivery Method, Performance - Potential Analysis
9.3. Global Bioengineered protein drugs Market Estimates & Forecasts by Drug Delivery Method 2019-2029 (USD Billion)
9.4. Bioengineered protein drugs Market, Sub Segment Analysis
9.4.1. Traditional Methods
9.4.2. Novel approaches according to recent research
Chapter 10. Global Bioengineered protein drugs Market, Regional Analysis
10.1. Bioengineered protein drugs Market, Regional Market Snapshot
10.2. North America Bioengineered protein drugs Market
10.2.1. U.S. Bioengineered protein drugs Market
10.2.1.1. Drug Type breakdown estimates & forecasts, 2019-2029
10.2.1.2. Diseases breakdown estimates & forecasts, 2019-2029
10.2.1.3. Technology breakdown estimates & forecasts, 2019-2029
10.2.1.4. Drug Delivery Method breakdown estimates & forecasts, 2019-2029
10.2.2. Canada Bioengineered protein drugs Market
10.3. Europe Bioengineered protein drugs Market Snapshot
10.3.1. U.K. Bioengineered protein drugs Market
10.3.2. Germany Bioengineered protein drugs Market
10.3.3. France Bioengineered protein drugs Market
10.3.4. Spain Bioengineered protein drugs Market
10.3.5. Italy Bioengineered protein drugs Market
10.3.6. Rest of Europe Bioengineered protein drugs Market
10.4. Asia-Pacific Bioengineered protein drugs Market Snapshot
10.4.1. China Bioengineered protein drugs Market
10.4.2. India Bioengineered protein drugs Market
10.4.3. Japan Bioengineered protein drugs Market
10.4.4. Australia Bioengineered protein drugs Market
10.4.5. South Korea Bioengineered protein drugs Market
10.4.6. Rest of Asia Pacific Bioengineered protein drugs Market
10.5. Latin America Bioengineered protein drugs Market Snapshot
10.5.1. Brazil Bioengineered protein drugs Market
10.5.2. Mexico Bioengineered protein drugs Market
10.5.3. Rest of Latin America Bioengineered protein drugs Market
10.6. Rest of The World Bioengineered protein drugs Market
Chapter 11. Competitive Intelligence
11.1. Top Market Strategies
11.2. Company Profiles
11.2.1. Abbott Laboratories
11.2.1.1. Key Information
11.2.1.2. Overview
11.2.1.3. Financial (Subject to Data Availability)
11.2.1.4. Product Summary
11.2.1.5. Recent Developments
11.2.2. Amgen
11.2.3. Baxter Healthcare
11.2.4. Bayer Healthcare Pharmaceuticals
11.2.5. Eli Lilly And Co.
11.2.6. GlaxoSmithKline
11.2.7. Hoffman-la-Roche
11.2.8. Johnson And Johnson
11.2.9. Merck And Co. Inc.,
11.2.10. Fresenius Kabi USA
Chapter 12. Research Process
12.1. Research Process
12.1.1. Data Mining
12.1.2. Analysis
12.1.3. Market Estimation
12.1.4. Validation
12.1.5. Publishing
12.2. Research Attributes
12.3. Research Assumption
LIST OF TABLES
TABLE 1. Global Bioengineered protein drugs Market, report scope
TABLE 2. Global Bioengineered protein drugs Market estimates & forecasts by Region 2019-2029 (USD Billion)
TABLE 3. Global Bioengineered protein drugs Market estimates & forecasts by Drug Type 2019-2029 (USD Billion)
TABLE 4. Global Bioengineered protein drugs Market estimates & forecasts by Diseases 2019-2029 (USD Billion)
TABLE 5. Global Bioengineered protein drugs Market estimates & forecasts by Technology 2019-2029 (USD Billion)
TABLE 6. Global Bioengineered protein drugs Market estimates & forecasts by Drug Delivery Method 2019-2029 (USD Billion)
TABLE 7. Global Bioengineered protein drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 8. Global Bioengineered protein drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 9. Global Bioengineered protein drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 10. Global Bioengineered protein drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 11. Global Bioengineered protein drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 12. Global Bioengineered protein drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 13. Global Bioengineered protein drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 14. Global Bioengineered protein drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 15. Global Bioengineered protein drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 16. Global Bioengineered protein drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 17. U.S. Bioengineered protein drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 18. U.S. Bioengineered protein drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 19. U.S. Bioengineered protein drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 20. Canada Bioengineered protein drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 21. Canada Bioengineered protein drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 22. Canada Bioengineered protein drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 23. UK Bioengineered protein drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 24. UK Bioengineered protein drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 25. UK Bioengineered protein drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 26. Germany Bioengineered protein drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 27. Germany Bioengineered protein drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 28. Germany Bioengineered protein drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 29. France Bioengineered protein drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 30. France Bioengineered protein drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 31. France Bioengineered protein drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 32. Italy Bioengineered protein drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 33. Italy Bioengineered protein drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 34. Italy Bioengineered protein drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 35. Spain Bioengineered protein drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 36. Spain Bioengineered protein drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 37. Spain Bioengineered protein drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 38. RoE Bioengineered protein drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 39. RoE Bioengineered protein drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 40. RoE Bioengineered protein drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 41. China Bioengineered protein drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 42. China Bioengineered protein drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 43. China Bioengineered protein drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 44. India Bioengineered protein drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 45. India Bioengineered protein drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 46. India Bioengineered protein drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 47. Japan Bioengineered protein drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 48. Japan Bioengineered protein drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 49. Japan Bioengineered protein drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 50. South Korea Bioengineered protein drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 51. South Korea Bioengineered protein drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 52. South Korea Bioengineered protein drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 53. Australia Bioengineered protein drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 54. Australia Bioengineered protein drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 55. Australia Bioengineered protein drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 56. RoAPAC Bioengineered protein drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 57. RoAPAC Bioengineered protein drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 58. RoAPAC Bioengineered protein drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 59. Brazil Bioengineered protein drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 60. Brazil Bioengineered protein drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 61. Brazil Bioengineered protein drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 62. Mexico Bioengineered protein drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 63. Mexico Bioengineered protein drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 64. Mexico Bioengineered protein drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 65. RoLA Bioengineered protein drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 66. RoLA Bioengineered protein drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 67. RoLA Bioengineered protein drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 68. Row Bioengineered protein drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 69. Row Bioengineered protein drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 70. Row Bioengineered protein drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 71. List of secondary sources, used in the study of global Bioengineered protein drugs Market
TABLE 72. List of primary sources, used in the study of global Bioengineered protein drugs Market
TABLE 73. Years considered for the study
TABLE 74. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
LIST OF FIGURES
FIG 1. Global Bioengineered protein drugs Market, research methodology
FIG 2. Global Bioengineered protein drugs Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Bioengineered protein drugs Market, key trends 2021
FIG 5. Global Bioengineered protein drugs Market, growth prospects 2022-2029
FIG 6. Global Bioengineered protein drugs Market, porters 5 force model
FIG 7. Global Bioengineered protein drugs Market, pest analysis
FIG 8. Global Bioengineered protein drugs Market, value chain analysis
FIG 9. Global Bioengineered protein drugs Market by segment, 2019 & 2029 (USD Billion)
FIG 10. Global Bioengineered protein drugs Market by segment, 2019 & 2029 (USD Billion)
FIG 11. Global Bioengineered protein drugs Market by segment, 2019 & 2029 (USD Billion)
FIG 12. Global Bioengineered protein drugs Market by segment, 2019 & 2029 (USD Billion)
FIG 13. Global Bioengineered protein drugs Market by segment, 2019 & 2029 (USD Billion)
FIG 14. Global Bioengineered protein drugs Market, regional snapshot 2019 & 2029
FIG 15. North America Bioengineered protein drugs Market 2019 & 2029 (USD Billion)
FIG 16. Europe Bioengineered protein drugs Market 2019 & 2029 (USD Billion)
FIG 17. Asia pacific Bioengineered protein drugs Market 2019 & 2029 (USD Billion)
FIG 18. Latin America Bioengineered protein drugs Market 2019 & 2029 (USD Billion)
FIG 19. Global Bioengineered protein drugs Market, company Market share analysis (2021)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
